Scarica l'app Stockscreener
40.00
7.32%
-3.16
Dopo l'orario di chiusura:
39.80
-0.20
-0.50%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Precedente Chiudi:
$43.16
Aprire:
$42.56
Volume 24 ore:
976.06K
Relative Volume:
2.98
Capitalizzazione di mercato:
$1.62B
Reddito:
$1.46B
Utile/perdita netta:
$92.09M
Rapporto P/E:
17.73
EPS:
2.2555
Flusso di cassa netto:
$47.29M
1 W Prestazione:
-27.13%
1M Prestazione:
-31.81%
6M Prestazione:
-8.59%
1 anno Prestazione:
+79.78%
Intervallo 1D:
$38.96
$42.98
Intervallo di 1 settimana:
$38.96
$58.74
Portata 52W:
$22.16
$60.08
Phibro Animal Health Corp Stock (PAHC) Company Profile
Nome
Phibro Animal Health Corp
Settore
Telefono
201-329-7300
Indirizzo
GLENPOINTE CENTRE EAST, 3RD FLOOR, TEANECK, NJ
Compare PAHC vs TAK, TEVA, HLN, ZTS, UTHR
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PAHC
Phibro Animal Health Corp
|
40.00 | 1.62B | 1.46B | 92.09M | 47.29M | 2.2555 |
TAK
Takeda Pharmaceutical Co Adr
|
16.46 | 52.00B | 29.85B | 776.90M | 4.35B | 0.2408 |
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
35.73 | 41.60B | 17.53B | 1.58B | 444.18M | 1.3457 |
HLN
Haleon Plc Adr
|
9.11 | 40.43B | 14.54B | 2.22B | 2.58B | 0.4871 |
ZTS
Zoetis Inc
|
82.83 | 34.72B | 9.47B | 2.67B | 2.28B | 6.0218 |
UTHR
United Therapeutics Corp
|
564.94 | 23.98B | 3.18B | 1.33B | 1.04B | 27.90 |
Phibro Animal Health Corp Stock (PAHC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-15 | Iniziato | Citigroup | Neutral |
| 2025-07-07 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2025-06-16 | Aggiornamento | BNP Paribas Exane | Underperform → Neutral |
| 2024-09-10 | Iniziato | JP Morgan | Neutral |
| 2023-12-07 | Iniziato | Exane BNP Paribas | Underperform |
| 2022-12-21 | Iniziato | ROTH Capital | Buy |
| 2022-07-25 | Downgrade | Barclays | Equal Weight → Underweight |
| 2022-01-10 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2021-11-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-08-05 | Ripresa | Credit Suisse | Neutral |
| 2021-07-07 | Downgrade | Barclays | Equal Weight → Underweight |
| 2020-08-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2020-02-06 | Downgrade | Gabelli & Co | Buy → Hold |
| 2020-01-28 | Aggiornamento | Barclays | Underweight → Equal Weight |
| 2019-09-05 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2019-08-29 | Reiterato | BofA/Merrill | Underperform |
| 2019-06-11 | Iniziato | Barclays | Underweight |
| 2019-05-23 | Iniziato | Guggenheim | Neutral |
| 2019-05-09 | Aggiornamento | Gabelli & Co | Hold → Buy |
| 2017-08-23 | Ripresa | BofA/Merrill | Underperform |
| 2017-06-02 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2016-12-15 | Iniziato | Piper Jaffray | Overweight |
| 2016-11-11 | Downgrade | Macquarie | Neutral → Underperform |
| 2016-11-10 | Downgrade | Gabelli & Co | Buy → Hold |
| 2016-04-11 | Reiterato | Guggenheim | Buy |
| 2016-02-04 | Iniziato | Credit Suisse | Outperform |
| 2016-01-15 | Downgrade | Barclays | Overweight → Underweight |
| 2015-09-30 | Iniziato | Gabelli & Co | Buy |
| 2015-04-24 | Reiterato | Barclays | Overweight |
| 2015-04-21 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2014-05-06 | Iniziato | Barclays | Overweight |
Mostra tutto
Phibro Animal Health Corp Borsa (PAHC) Ultime notizie
Q3 2026 Phibro Animal Health Corp Earnings Call Transcript - GuruFocus
PAHCPhibro Animal Health Corp Stock Price and Quote - Finviz
Phibro Sustainable Solutions Platform helps protein producers target greenhouse gas emissions - The National Provisioner
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? - Yahoo! Finance Canada
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares By Investing.com - Investing.com Australia
Phibro Animal Health CEO Jack Bendheim sells $1.02m in PAHC shares - Investing.com
CEO-linked BFI Co. (PAHC) sells 18,608 Phibro shares under plan - Stock Titan
Phibro executives take Bank of America health conference stage May 13 - Stock Titan
Phibro Animal Health Corporation to Participate in Bank of America Securities Health Care Conference - Yahoo Finance
Phibro Q3 FY2026 slides: 10% sales growth amid regulatory headwinds - Investing.com
Earnings call transcript: Phibro Animal Health beats Q3 2026 expectations - Investing.com
Phibro Animal Health Reports Strong Q3 2026 Results, Raises Full-Year Guidance with 14% Sales Growth - Minichart
Phibro Animal Health Corp reports results for the quarter ended March 31Earnings Summary - TradingView
MSN Money - MSN
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics - Yahoo! Finance Canada
Phibro Animal Health (PAHC) Q3 Earnings and Revenues Surpass Estimates - Yahoo Finance
Phibro: Fiscal Q3 Earnings Snapshot - KVUE
Phibro Animal Health (PAHC) posts 10% Q3 sales growth and raises 2026 guidance - Stock Titan
Phibro Animal Health’s (NASDAQ:PAHC) Q1 CY2026: Beats On Revenue - Yahoo Finance
Animal health demand pushes Phibro sales to $383.5M in Q3 - Stock Titan
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance - marketscreener.com
Phibro Animal Health (PAHC) lifts sales and profit in Q3 2026 - Stock Titan
Phibro Animal Health earnings on deck: Can MFA momentum hold? - Investing.com
Phibro Animal Health Corporation Launches Companywide Sustainable Solutions Platform; Introduces VERRATAIN™ Verified Sustainability Solutions Through Strategic VAXA Technologies Partnership - 01net
Phibro Animal Health Corporation Launches Companywide Sustainable - The National Law Review
Phibro Animal Health declares $0.12 quarterly dividend payable June 24 - TradingView
[8-K] PHIBRO ANIMAL HEALTH CORP Reports Material Event - Stock Titan
Phibro sets June 24 payout for $0.12-a-share quarterly dividend - Stock Titan
How Investors Are Reacting To Phibro Animal Health (PAHC) Expanding Its Revolving Credit Facility - Yahoo Finance
Phibro Animal Health Corp (PAHC) Stock Up 3.1% but GF Value Says Overvalued -- GF Score: 73/100 - GuruFocus
Phibro Animal Health (NASDAQ:PAHC) CEO Sells $393,606.40 in Stock - MarketBeat
Insider Selling: Phibro Animal Health (NASDAQ:PAHC) CEO Sells 7,040 Shares of Stock - MarketBeat
Phibro Animal Health CEO Bendheim-linked entity sells $1.1m stock - Investing.com Australia
Phibro Animal Health CEO Bendheim-linked entity sells $1.1m stock By Investing.com - Investing.com South Africa
CEO-associated BFI Co. trims Phibro (PAHC) stake under 10b5-1 plan - Stock Titan
Phibro Animal Health (NASDAQ: PAHC) raises revolver to $435M - Stock Titan
Phibro Animal Health Corp (NASDAQ: PAHC) — Vanguard holds 5.06% stake - Stock Titan
Precision Wealth Strategies LLC Purchases Shares of 41,973 Phibro Animal Health Corporation $PAHC - MarketBeat
Phibro investors get Q3 results May 6, webcast the next morning - Stock Titan
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results - Yahoo Finance
Phibro Animal Health Corporation Announces Regulatory Framework Change in Brazil for Antimicrobials - The National Law Review
Phibro Animal Health (PAHC) to Release Earnings on Wednesday - MarketBeat
Phibro Animal Health Corp (PAHC) Shares Fall 3.3% -- GF Value Sa - GuruFocus
Phibro Animal Health's (PAHC) CEO Sold 21,120 Shares for $1.2 Million - Yahoo Finance
Zacks Industry Outlook Highlights Phibro Animal Health, BioLife Solutions, Omeros and Brainsway - Yahoo Finance
Phibro Animal Health (PAHC) to Adapt to New Brazilian Antimicrob - GuruFocus
Assessing Phibro Animal Health (PAHC) Valuation After Powerful Share Price Momentum - Yahoo Finance
Phibro Animal Health Corp Azioni (PAHC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.49%
1.78%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):